Efficacy and Safety of First-line Anti-PD-1/PD-L1 Monoclonal Antibody in Combination With Chemotherapy and Bronchoscopy-assisted Interventional Therapy in Patients With Advanced Central Non-small Cell Lung Cancer
Clinical trial NCT04702009 · COMPLETED
Trial details
- NCT number
- NCT04702009
- Sponsor
- Shanghai Pulmonary Hospital, Shanghai, China
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-20
- Primary completion
- 2025-10-17
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.